Диссертация (1154697), страница 19
Текст из файла (страница 19)
Urethral strictures following high-dose-rate brachytherapy forprostate cancer: analysis of risk factors / Hindson B.R., Millar J.L., Matheson B. //Brachytherapy. — 2013. – Vol.12(1). – P.50-55.11871.Holm, H.H. Ultrasonically guided precise needle placement in the prostateand seminal vesicles / H.H. Holm, J. Gammelgaard // J.
Urol. — 1981. — Vol. 18. —N 3. — P. 385-387.72.Holmium laser endourethrotomy for the treatment of long-segment urethralstrictures: a retrospective study of 190 patients. / Liu Q., Ma W., Li X. [et al.] // Urol J.— 2014. — Vol.3;11(1). — P.1264-70.73.Hu, K. Urinary incontinence in patients who have a TURP/TUIP followingprostate brachytherapy / K.
Hu, K.E. Wallner // Int. J. Radiat. Oncol. Biol. Phys. — 1998.— Vol. 40. — P. 783-786.74.Identifying the predictors of acute urinary retention following magnetic-resonance-guidedprostate brachytherapy / M.D. Thomas, R. Cormack, C.M. Tempany,[et al.] // Int. J. Radiat. Oncol. Biol. Phys. — 2000. —Vol.
47. — P. 905-908.75.Impact of experience and technical changes on acute urinary and rectalmorbidity in low-dose prostate brachytherapy using loose seeds real-time implantation /Le Fur E., Malhaire J.P., Nowak E., Rousseau B. [et al.] // Brachytherapy. 2013.Vol.12(6). – P.589-95.76.Iodine-125 seed implantation and deferred transurethral resection of theprostate for patients with lower urinary tract symptoms and localized prostate cancer /Liu R., Luo F., Zhang Z., Xu Y. // Clin. genitourin cancer.
— 2013. — Vol. 11 (3). —P. 251–255.77.Iodine-125 thin seeds decrease prostate swelling during transperinealinterstitial permanent prostate brachytherapy / Beydoun N., Bucci J.A., Chin Y.S.,Malouf D. // J. Med. Imaging. Radiat. Oncol. — 2014. – Vol. 58(1) – P. 109-116.78.Is there a relation between the radiation dose to the different sub-segmentsof the lower urinary tract and urinary morbidity after brachytherapy of the prostate withI-125 seeds? / Steggerda M.J., Witteveen T., van den Boom F, Moonen L.M.
//Radiotherapy Oncology. 2013. – Vol.109(2). – P.251-255.79.Ishiyama, H. Is There an Increase in genitourinary toxicity in patients treatedwith transurethral resection of the prostate and radiotherapy?: a systematic review /Ishiyama H, Hirayama T, Jhaveri P. // Am. j. clin. oncol. — 2014. — Vol.37 (3). —119P.297-30480.Jain, S.K. Evaluation of holmium laser versus cold knife in optical internalurethrotomy for the management of short segment urethral stricture / Jain S.K.,Kaza R.C., Singh BK. // Urol Ann. 2014. — Vol.6 (4).
— P.328-333.81.Kishan, A.U. Late rectal toxicity after low-dose-rate brachytherapy:incidence, predictors, and management of side effects / Kishan A.U., Kupelian P.A. //Brachytherapy. —2015. – Vol.14(2). – P.148-159.82.Kragelj, B. Urinary incontinence after high-dose-rate brachytherapy boosttreatment for prostate cancer / Kragelj B., Zaletel-Kragelj L. // Brachytherapy. 2016. Vil.15(4). – P.442-449.83.Kukiełka, A.M. High-dose-rate brachytherapy as a monotherapy for prostatecancer--Single-institution results of the extreme fractionation regimen / Kukiełka A.M.,Dąbrowski T., Walasek T.
// Brachytherapy. — 2015. — Vol.14 (3). — P.359-365.84.Late toxicity and five year outcomes after high-dose-rate brachytherapy as amonotherapy for localized prostate cancer / Ghadjar P., Oesch S.L., Rentsch C.A.[et al.] // Radiat Oncol. — 2014. — Vol.28 (9).
— P.122.85.Late Urinary Side Effects 10 Years After Low-Dose-Rate ProstateBrachytherapy: Population-Based Results From a Multiphysician Practice Treating Witha Standardized Protocol and Uniform Dosimetric Goals / Keyes M., Miller S., Pickles T.[et al.] // International Journal of Radiation Oncology Biology Physics. — 2014. — Vol.90(3). – P.570-578.86.Leapman, M.S. Urinary Incontinence Following Prostate Brachytherapy /Leapman M.S., Stone N.N., Mock S. // Urology. — 2016. — Vol.95. — P.151-157.87.Li, G. A Fully Actuated Robotic Assistant for MRI-Guided Prostate Biopsyand Brachytherapy / Li G. // Proc. Soc.
Photo. Opt. Instrum. Eng. — 2013. —P.8671:867117.88.Lin, Y. Bipolar button-electrode plasma vaporization of the prostate: Aneffective option for patients with post-brachytherapy retention / Lin Y, Liu B, Xie L. //Exp Ther Med. — 2015. — Vol.10 (4). — P.1309-1310.89.Long-term efficacy andtoxicity oflow-dose-rate125Iprostate120brachytherapy as monotherapy in low-, intermediate-, and high-risk prostate cancer /Kittel, J.A., Reddy, C.A., Smith, K.L. [et al.] // Int. J. Radiat.
Oncol. — 2015. — Vol. 92.— P.884–893.90.Long-term erectile function following permanent seed brachytherapytreatment for localized prostate cancer / Ong W.L., Hindson B.R., Beaufort C. [et al.] //Radiother Oncol. — 2014. — Vol.112. — №1. — P.72-76.91.Long-term Toxicity and Health-related Quality of Life after Single-fractionHigh Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapyfor Intermediate-risk Prostate Cancer / Shahid N., Loblaw A., Chung H.T. [et al.] //Clinical Oncology. — 2017.
— Vol. 29(7). – P.412-420.92.Lowdose rate brachytherapy for patients with low- or intermediateriskprostate cancer: A systematic review / Rodrigues G., Yao X., Loblaw D.A. [et al.] // Can.Urol. Assoc. J. — 2013. — Vol.7. — №11-12. — P.463–470.93.Management of bladder neck stenosis and urethral stricture and stenosisfollowing treatment for prostate cancer / Nicholson H.L., Al-Hakeem Y., Maldonado J.J.,Tse V. // Transl. Androl. Urol. — 2017. – Vol.6(2).
– P.92-102.94.Management of high-risk prostate cancer: radiation therapy and hormonaltherapy / Nomiya T., Tsuji H., Toyama S. [et al.] // Cancer Treat Rev. — 2013. — Vol.39.— №8. — P.872-878.95.Manual vs. automated implantation of seeds in prostate brachytherapy:Oncologic results from a single-center study / Thomas L., Chemin A., Leduc N.,Belhomme S. [et al.] // Brachytherapy. — 2018. – Vol.17(1). – P.214-220.96.Martínez, P.F. Comparison of the Biochemical Recurrence risk betweenRadical Prostatectomy and Brachytherapy in the treatment of low- and intermediate-riskprostate cancer / Martínez P.F., Belisle D.F., Cristallo C. // Arch Esp Urol. — 2015.
—Vol.68 (8). —P.655-660.97.Mazur, A.W. Efficacy and morbidity of «channel» TURP / A.W. Mazur,I.M. Thompson // Urol. — 1991. — Vol. 38. — N 6. — P. 526-528.98.Mid-term outcome of permanent prostate iodine-125 brachytherapy inJapanese patients / Kimura T., Kido M., Miki K. [et al.] // Int J Urol. — 2014.
—121Vol.21 (5). — P. 473-478.99.Milose, J.C. Urethroplasty in radiationinduced strictures / Milose J.C.,Gonzalez CM. // Current Opinion in Urology. — 2014. — Vol.25. — №4. — P.336–340.100. Multiparametric MRI in the diagnosis of prostate cancer / Ahverdiev G.I.,Sanai E.B., Panov V.O. [et al.] // Russian Electronic Journal of Radiology. — 2013.
—vol. 3. — № 4. — РР. 109—119.101. Multi-variable models predicting specific patient-reported acute urinarysymptoms after radiotherapy for prostate cancer: Results of a cohort study / Cozzarini C,Rancati T, Carillo V. [et al.] // Radiother Oncol. — 2015. — Vol.116 (2). — P.185-191.102. Nanda, A. Neoadjuvant Hormonal Therapy Use and the Risk of Death inMen with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a SingleRisk Factor for Coronary Artery Disease / Nanda A. // Eur. urol. — 2014. — Vol. 65. —№1.
— P. 177–185.103. Nationwide,multicenter,retrospectivestudyonhigh-dose-ratebrachytherapy as monotherapy for prostate cancer /Yoshioka, Y. [et al.] // Int. J. Radiat.Oncol. Biol. Phys. — 2017 – Vol.97(5). – P. 952–961.104. Ong, WL. Decline in acute urinary toxicities with increased institutionalexperience: 15-year experience of permanent seed prostate brachytherapy in a singleAustralasian institution / Ong W.L., Matheson B., Millar J. // Brachytherapy. — 2017. —Vol.16. — №2.
—P.313-322.105. Outcomes Associated With 3 Treatment Schedules of High-Dose-RateBrachytherapy Monotherapy for Favorable-Risk Prostate Cancer / Jawad MS, DilworthJT, Gustafson GS. [et al.] // Int J Radiat Oncol Biol Phys. — 2016. — Vol.15. — 94(4). —P. 657-666.106. Outcomes of surgical treatment of ureteral strictures after laserureterolithotripsy for impacted stones / Srougi V., Padovani G.P., Marchini G.S. [et al.] //Can J Urol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
